Usually, breast cancer can be divided into luminal (luminal A and luminal B), triple negative, and HER-2 positive based on the expression of estrogen receptor (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.